Business
Press Release Aug 22 2023
Marksans Pharma Limited has informed the Exchange regarding a press release dated August 22, 2023, titled "Receipt of USFDA approval for Guaifenesin Extended-Release Tablets (OTC)".
About this update from Marksans Pharma Limited
[{"type":"text","content":" Marksans Pharma Limited has informed the Exchange regarding a press release dated August 22, 2023, titled \"Receipt of USFDA approval for Guaifenesin Extended-Release Tablets (OTC)\". View Attachment","length":326,"tagName":"div"}]